EAM Investors, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2020$1,182,000
-52.2%
23,126
-25.6%
0.37%
-32.5%
Q4 2019$2,471,000
+3.7%
31,085
-37.0%
0.54%
+37.0%
Q1 2018$2,382,000
+33.1%
49,311
+8.5%
0.40%
+24.1%
Q4 2017$1,789,000
-16.4%
45,460
-34.1%
0.32%
+12.3%
Q3 2017$2,141,000
-12.8%
68,961
-23.2%
0.28%
-29.8%
Q2 2017$2,455,000
-30.8%
89,750
-6.7%
0.41%
-27.4%
Q1 2017$3,546,00096,2250.56%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2017
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders